N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states

Clinical Endocrinology

Volumn 60, Issue 1, 2004, Pages 54-59

  Schultz, Marianne ^a   Faber, Jens ^a   Kistorp, Caroline ^a   Jarløv, Anne ^a   Pedersen, Frants ^a   Wiinberg, Niels ^a   Hildebrandt, Per ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GOITER; HEALTH STATUS; HEART DISEASE; HEART OUTPUT; HEART RATE; HUMAN; IMPEDANCE CARDIOGRAPHY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THYROID DISEASE; THYROID FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTITHYROID AGENTS; CARDIAC OUTPUT; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; REGRESSION ANALYSIS; THYROID DISEASES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0842309242     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.01941.x     Document Type: Article

References (25)

1. Baughman, K. (2002) B-type natriurctic peptide - a window to the heart. New England Journal of Medicine, 347, 158-159.
2. Clerico, A., Iervasi, G., Del Chicca, M.G., Emdin, M., Maffei, S., Nannipier, M., Sabatino, L., Forini, F., Manfredi, C. & Donato, L. (1998) Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometnc assays in normal subjects and in patients with different degrees of heart failure. Journal of Endocrinological Investigation, 21, 170-179.
3. Faber, J. & Galløe, A.M. (1994) Changes in bone mass during prolonged subclinical hypcrthyroidism due to 1-thyroxine treatment: a meta-analysis. European Journal of Endocrinology, 130, 350-356.
4. Faber, J., Wiinberg, N., Schifter, S. & Mehlsen, J. (2001) Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. European Journal of Endocrinology. 145, 391-396.
5. Faber, J., Petersen, L., Wiinberg, N., Schifter, S. & Mehlsen, J. (2002) Hemodynamic changes after levothyroxinc treatment in subclinical hypothyroidism. Thyroid, 12, 319-324.
6. Hammerer-Lercher, A., Neubauer, E., Müller, S., Pachinger, O., Puschendorf, B. & Mair, J. (2001) Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clinica Chimica Acta, 310, 193-197.
7. Hunt, P.J., Richards, A.M., Nicholls, M.G., Yandle, T.G., Doughty, R.N. & Espiner, E.A. (1997) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clinical Endocrinology, 47, 287-296.
8. Klein, I. & Levey, G.S. (1996) The cardiovascular system in thyrotoxicosis. In: Werner and Ingbar's the Thyroid (ed. L.E. Braverman & R.D. Utiger), 7th edn, Chapter 38 pp. 607-615. JB Lippincott, Philadelphia.
9. Klein, I. & Ojamaa, K. (1996) The cardiovascular system in hypothyroidism. In: Werner and Ingbar's the Thyroid (ed. L.E. Braverman & R.D. Utiger), 7th edn, Chapter 62, pp. 799-804. JB Lippincott, Philadelphia.
10. Klein, I. & Ojamaa, K. (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344, 501-509.
11. Kohno, M., Horio, T., Yasunari, K., Yokokawa, K., Ikeda, M., Kurihara, N., Nishizawa, Y., Morii, H. & Takeda, T. (1993) Stimulation of brain peptide release from the heart by thyroid hormone. Metabolism, 42, 1059-1064.
12. Liang, F., Webb, P., Marimuthu, A., Zhang, S. & Gardner, D.G. (2003) Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. Journal of Biological Chemistry, 278, 15073-15083.
13. Mair, J. (2002) Role of cardiac natriuretic peptide testing in heart failure. Clinical Chemistry, 48, 977-978.
14. Maisel, A.S. (2003) Nesiritide: a new therapy for the treatment of heart failure. Cardiovascular Toxicology, 3, 37-42.
15. Maisel, A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., Omland, T., Storrow, A.B., Abraham, W.T., Wu, A.H.B., Clopton, P., Steg, P.G., Westheim, A., Knudsen, C.W., Perez, A., Kazanegra, R., Herrmann, H.C. & McCullough, P.A. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine, 347, 161-167.
16. Mehlsen, J., Bonde, J., Stadeager, C., Rehling, M., Tango, M. & Trap-Jensen, J. (1991) Reliability of impedance cardiography in measuring central haemodynamics. Clinical Physiology, 11, 579-588.
17. Morrison, L.K., Harrison, A., Krishnaswamy, P., Kazanegra, R., Clopton, P. & Maisel, A. (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. Journal of the American College of Cardiology, 39, 202-209.
18. Nakagawa, O., Ogawa, Y., Itoh, Y., Suga, S., Komatsu, Y., Kishimoto, I., Nishino, K., Yoshimasa, T. & Nakao, K. (1995) Rapid transcriptional activation and early mRNA turnover and brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. Journal of Clinical Investigation, 96, 1280-1287.
19. Nielsson, J.C., Groenning, B.A., Nielsen, G., Fritz-Hansen, T., Trawinski, J., Hildebrandt, P.R., Jensen, G.B., Larsson, H.B. & Soendergaard, L. (2002) Left ventricular remodelling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. American Heart Journal, 143, 696-702.
20. Pemberton, C.J., Johnson, M.L., Yandle, T.G. & Espiner, E.A. (2000) Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension, 36, 355-359.
21. Richards, A.M., Nicholls, M.G., Yandle, T.G., Frampton, C., Espiner, E.A., Turner, J.G., Buttimore, R.C., Lainchbury, J.G., Elliott, J.M., Ikram, H., Crozier, I.G. & Smyth, D.W. (1998) Plasma N-terminal probrain natriuretic peptide and adrenomedullin. New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation, 97, 1921-1929.
22. Richards, A.M., Doughty, R., Nicholls, M.G., MacMahon, S., Sharpe, N., Murphy, J., Espiner, E.A., Frempton, C. & Yandle, T.G. (2001) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Journal of the American College of Cardiology, 37, 1781-1787.
23. Shimoike, H., Iwai, N. & Kinoshita, M. (1997) Different regulation of natriuretic peptide genes in infarcted rat hearts. Clinical and Experimental Pharmacology and Physiology, 24, 23-30.
24. Silva, J.E. (1996) Catecholamines and the sympathoadrenal system in thyrotoxicosis. In: Werner and Ingbar's the Thyroid (ed. L.E. Braverman & R.D. Utiger), 7th edn, Chapter 46, pp. 661-670. JB Lippincott, Philadelphia.
25. Tsutamoto, T., Wada, A., Maeda, K., Hisanaga, T., Maeda, Y., Fukai, D., Ohnishi, M., Sugimoto, Y. & Kinoshita, M. (1997) Attenuation of compensation of endogenous cardiac natnuretic peptide system in chronic heart failure. Circulation, 96, 509-516.